Details of the Drug
General Information of Drug (ID: DMXG10E)
Drug Name |
1-(2-Phenyl-propyl)-3-thiazol-2-yl-thiourea
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Thiourea, N-(2-phenylpropyl)-N'-2-thiazolyl-; 149486-09-9; PETT Analog 33; AC1MHDKK; BDBM1867; CHEMBL144136; 1-(2-phenylpropyl)-3-thiazol-2-yl-thiourea; 1-(beta-Methylphenethyl)-3-(2-thiazolyl)thiourea; 1-(2-phenylpropyl)-3-1,3-thiazol-2-ylthiourea; 1-(2-phenylpropyl)-3-(1,3-thiazol-2-yl)thiourea; N-(1-(2-Phenylpropyl))-N -(2-thiazolyl)thiourea
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 277.4 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 3.2 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References